Transcription factor Nrf2 as a potential therapeutic target for COVID-19

Yifan Wang,Jing Ma,Yongfang Jiang
DOI: https://doi.org/10.1007/s12192-022-01296-8
2022-01-01
Cell Stress and Chaperones
Abstract:The coronavirus disease 2019 (COVID-19) is caused by a novel severe acute respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with SARS-COV-2 infection frequently exhibit signs of high oxidative stress and systemic inflammation, which accounts for most of the mortality. Antiviral strategies to inhibit the pathogenic consequences of COVID-19 are urgently required. The nuclear factor erythroid 2–related transcription factor (Nrf2) is a transcription factor that is involved in antioxidant and anti-inflammatory defense in several tissues and cells. This review tries to present an overview of the role of Nrf2 in the treatment of COVID-19.
What problem does this paper attempt to address?